你即將離開本站

並前往https://www.businesswire.com/news/home/20220420005466/en/Arcturus-Announces-Self-amplifying-COVID-19-mRNA-Vaccine-Candidate-ARCT-154-Meets-Primary-Efficacy-Endpoint-in-Phase-3-Study

Arcturus Announces Self-amplifying COVID-19 mRNA ...

Arcturus Announces Self-amplifying COVID-19 mRNA Vaccine Candidate ... “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA ...

確定！ 回上一頁

查詢 「Mrna nasdaq」的人也找了：